Benitec Biopharma
BNTC
$8.87
Share price
7.89%
Change (1 day)
4,334.30%
Change (1 year)
Benitec Biopharma (BNTC) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $5.88 M
According to Benitec Biopharma 's latest financial reports the company's total liabilities are $5.88 M. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Benitec Biopharma - Total liabilities on balance sheet (from 2020 to 2019)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-06-30 | $4.26 M | 37.88% |
| 2022-06-30 | $3.09 M | 125.79% |
| 2021-06-30 | $1.36 M | 1.48% |
| 2020-06-30 | $1.34 M | -27.27% |
| 2019-06-30 | $1.85 M | 31.51% |
| 2018-06-30 | $1.41 M | 105.88% |
| 2017-06-30 | $0.68 M | 16.62% |
| 2016-06-30 | $0.58 M | -39.21% |
| 2015-06-30 | $0.96 M | -33.62% |
| 2014-06-30 | $1.45 M | 82.98% |
| 2013-06-30 | $0.79 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Nymox Pharmaceutical NYMX | $3.14 M | -46.49% | Bahamas |
 NRC Health
NRC | $73.48 M | 1,149.06% | 🇺🇸 USA |